© 2024 MJH Life Sciences™ and Patient Care Online. All rights reserved.
Grace Halsey
Articles
What do Patients Want from Telehealth?
September 30, 2024
Telehealth offers convenience, saves time, and offers other benefits over office visits, but many people don't even know it's available to them, a new survey found.
FDA Approval of Dupilumab for Uncontrolled COPD will Change the Treatment Landscape: Interview with Surya Bhatt, MD, MSPH
September 27, 2024
Surya Bhatt, MD, MSPH, is coprincipal investigator for the 2 pivotal phase 3 clinical trials that supported today's landmark FDA approval of dupilumab for COPD.
Dupilumab Becomes First Biologic Approved in the US as Targeted Therapy for Adults with COPD
September 27, 2024
Dupilumab represents the first new treatment approach for uncontrolled COPD in more than a decade and reduced disease exacerbations by 34% in clinical trials.
New Oral Migraine Drugs Less Effective than Triptans for Acute Migraine Treatment
September 26, 2024
Triptan medications outperformed newer classes of oral migraine drugs, ie, gepants and ditans, on standard measures of efficacy for acute treatment.
Cancer Diagnosis Rates in 2021 Still Lagged Behind Projections Following Pandemic Effects
September 26, 2024
The decline in cancer diagnoses during the COVID-19 shutdown in 2020 did not lead to an expected compensatory increase in diagnoses in 2021, according to NCI researchers.
Lebrikizumab Demonstrates Sustained Disease Control in Atopic Dermatitis Up to 3 Years
September 25, 2024
Among adolescents and adults with moderate-to-severe AD, more than 80% achieved sustained disease control, the majority not requiring topical or systemic rescue medication.
Preconception Prediabetes Ups Risk for Poor Pregnancy Outcomes in Young Women: New Data
September 25, 2024
The risk of gestational diabetes was 2-fold greater among young women with prediabetes before conceiving compared with those who had normoglycemia.
FDA Accepts NDA for Delgocitinib Cream, Developed Specifically to Treat Chronic Hand Eczema
September 24, 2024
Delgocitinib specifically inhibits activation of JAK-STAT signaling in chronic hand eczema and would be an option for people unable to use topical corticosteroids.
COVID-19 Vaccines 2024-2025: Is America Ready and Willing?
September 23, 2024
COVID-19 vaccine myths of many types remain potent enough to raise public health experts' concerns about Americans' willingness to roll up sleeves this year.
Real-World Study Supports Use of DermaSensor in Primary Care to Differentiate Cancerous and Benign Lesions
September 23, 2024
The AI-based point-of-care device outperformed clinician standard of care for sensitivity (90% vs 40%) and had a negative predictive value of 98.9%